Company News »

Arrowhead to Present at Jefferies 2015 Healthcare Conference

Business Wire
Share on StockTwits
Published on

Arrowhead Research Corporation (NASDAQ:ARWR) , a biopharmaceutical company developing targeted RNAi therapeutics, today announced that Arrowhead’s president and chief executive officer Christopher Anzalone, Ph.D., will present a corporate overview at the Jefferies 2015 Healthcare Conference on June 3, 2015 at 10:00 a.m. EDT.

Investors may access live and archived versions of the audio webcast of this presentation on the Events and Presentations page of the Company’s website at

About Arrowhead Research Corporation

Arrowhead Research Corporation is a biopharmaceutical company developing targeted RNAi therapeutics. The company is leveraging its proprietary Dynamic Polyconjugate delivery platform to develop targeted drugs based on the RNA interference mechanism that efficiently silences disease-causing genes. Arrowhead’s pipeline includes ARC-520 for chronic hepatitis B virus and ARC-AAT for liver disease associated with Alpha-1 antitrypsin deficiency.

For more information please visit, or follow us on Twitter @ArrowRes. To be added to the Company’s email list and receive news directly, please visit

Source: Arrowhead Research Corporation

Share on StockTwits